Animal study · mice

GHK-Cu reduced smoke-induced muscle loss and weakness in mice

Checked against the paper Animal studyPublished by PepVault

The takeaway

This adds early mouse and cell evidence that GHK-Cu protected muscle from smoking damage; giving it to people was not part of this study.

Kind
Animal study
Studied in
Mice
Published
2023
Journal
J Cachexia Sarcopenia Muscle

What they tested

The team asked whether the natural peptide GHK plays a role in muscle weakness linked to COPD (chronic obstructive pulmonary disease) and smoking, and whether GHK-Cu could protect muscle from cigarette smoke damage.

How the study was done

Preclinical work in C2C12 myotubes (muscle cells grown in a dish) and in C57BL/6 mice exposed to cigarette smoke, given GHK-Cu at 0.2 or 2 mg/kg. The team also measured natural GHK levels in the blood of 9 people with COPD and 11 healthy people of similar age.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking GHK-Cu? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In smoke-exposed mice, GHK-Cu limited muscle loss: skeletal muscle weight was 1.29% and 1.40% in the two dose groups versus 1.19% without treatment, and muscle cross-sectional area was 1797 and 2252 μm2 versus 1055 μm2. Grip strength in the mice rose to 257.6 g and 339.1 g from 175.5 g. In the cells, GHK-Cu raised myosin heavy chain, a muscle protein, lowered the muscle-breakdown markers MuRF1 and atrogin-1, and increased mitochondrial content, and the team linked these effects to the protein SIRT1. In people, blood GHK was lower in COPD patients than in healthy people (70.27 vs 133.0 ng/mL, P = 0.009), and higher levels went with larger pectoralis muscle area.

What it doesn’t show

The treatment results come from mice and cells, not people; no person in this study was given GHK-Cu. The human part was small, with 9 patients and 11 controls, and only measured natural GHK levels, so it shows a link rather than cause.

The paper

Deng et al. Glycyl-l-histidyl-l-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway. J Cachexia Sarcopenia Muscle. 2023.

The compound

More studies on GHK-Cu

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking GHK-Cu? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo